Chemopreventive effects of sarcophine-diol on skin tumor development in CD-1 mice

Cancer Lett. 2007 Aug 8;253(1):53-9. doi: 10.1016/j.canlet.2007.01.009. Epub 2007 Feb 23.

Abstract

The objective of this study was to determine the chemopreventive effects of sarcophine-diol (SD) on 7,12-dimethylbenz(a)anthracene initiated and 12-O-tetradecanoylphorbol-13-acetate promoted skin tumor development in mice and its possible mechanisms of action. SD pretreatment significantly (P<0.05) decreased skin papilloma development during promotion phase. SD significantly (P<0.05) increased caspase-3 and decreased cyclooxygenase-2 during initiation phase or promotion phase. SD significantly (P<0.05) increased caspase-8 during promotion phase. SD resulted in a 95% reduction in 12-O-tetradecanoylphorbol-13-acetate-induced DNA synthesis. SD could be an effective chemopreventive agent for skin cancer by enhancing apoptosis and decreasing cell proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-Butyrolactone / analogs & derivatives*
  • 4-Butyrolactone / pharmacology
  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Apoptosis / drug effects
  • Carcinogens
  • Caspase 3 / metabolism
  • Caspase 8 / metabolism
  • Caspase 9 / metabolism
  • Cell Proliferation / drug effects
  • Cyclooxygenase 2 / metabolism
  • Female
  • Mice
  • Papilloma / chemically induced
  • Papilloma / metabolism
  • Papilloma / prevention & control*
  • Skin Neoplasms / chemically induced
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / prevention & control*
  • Tetradecanoylphorbol Acetate

Substances

  • Carcinogens
  • sarcophine
  • 9,10-Dimethyl-1,2-benzanthracene
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Caspase 3
  • Caspase 8
  • Caspase 9
  • Tetradecanoylphorbol Acetate
  • 4-Butyrolactone